Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Zhou GH, Li XK, Hein DW, Xiang XL, Marshall JP, Prabhu SD, et al
Ultimately, finding the right balance requires collaboration with pharmacy benefit managers (PBMs) and healthcare consultants to create coverage based on workforce needs and risk factors
Major biopharmaceutical companies, including Novo Nordisk, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Eccogene, AstraZeneca, and others, are driving innovation in the GLP-1 agonists space through robust pipelines, strategic collaborations, and the development of next-generation treatments targeting diabetes, obesity, and related metabolic disorders
M.SummanenP
US$ 23.51
US$ 25.39
US$ 20.45
US$ 29.53
